## Abstract The leukocyte adherence inhibition (LAI) assay was utilized as a test for cellular immunity to Epstein‐Barr virus (EBV) antigens in 22 patients with infectious mononucleosis (IM), 47 patients with lymphoma, 101 carcinoma patients, and 84 subjects without cancer. Response to EB virion (“
EBV antigens in lymphocytes of patients with exudative tonsillitis, infectious mononucleosis and hodgkin's disease
✍ Scribed by Robert W. Veltri; James E. McClung; Philip M. Sprinkle
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 636 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A protocol utilizing isokinetic gradients to isolate human lymphocytes is combined with another that purifies the C3 receptor‐bearing B lymphocyte subpopulation, thus enriching the EB virus genome‐carrying population. Also, rabbit antisera were prepared to the Epstein‐Barr virus nuclear antigen (EBNA) and the early antigen (EA) and utilized in an indirect immunofluorescence test (IIT) to detect these antigens in human lymphocytes isolated from various disease states. Using these methods we demonstrated excellent correlation between standard methods previously employed to detect EB virus‐coded antigens and our IIT employing xenogenic antisera. Such tests were done on lymphoblastoid cell lines as well as lymphocytes isolated directly from patients with EB vims lymphoproliferative diseases. Human palatine tonsil‐derived lymphocytes from children with exudative tonsillitis and peripheral blood lymphocytes of infectious mononucleosis contained only EBNA in C3 receptor‐bearing B lymphocytes. However, patients with lymphoproliferative disorders, including Hodgkin's disease, harbored in their spleens and lymph nodes lymphocytes producing both EBNA and EA.
📜 SIMILAR VOLUMES
## Abstract Patients with a positive reaction to the Paul‐Bunnell test in the period 1961–72 were identified at nine different laboratories in Norway and matched against cases of malignant lymphoma registered at the Cancer Registry of Norway in the period 1961–75. Among 5, 840 patients having a pos
## Abstract Infectious mononucleosis (IM) is an established risk factor for Hodgkin's disease (HD). A substantial minority (33%) of cases of HD have Epstein‐Barr virus (EBV) DNA within the malignant cells (are EBV^+ve^). It is unclear whether risk after IM applies specifically to EBV^+ve^ HD. We re
## Epstein-Barr virus (EBV) is detected in Hodgkin and Reed-Sternberg (HRS) cells in up to 50% of patients with Hodgkin's disease (HD). HD patients have been reported to express high serum titers against EBV antigens, even prior to the diagnosis of HD. Patients with high serum titers have a poorer
DNA from malignant cells is present in the serum/plasma of cancer patients and DNA from this source is amenable to analysis by polymerase chain reaction (PCR). In the present study, we evaluated whether Epstein-Barr virus (EBV) DNA is present in the serum of patients with EBV-associated Hodgkin's di